Antioxidants and ocular cell type differences in cytoprotection from formic acid toxicity in vitro.
Retinal photoreceptors and retinal pigment epithelial (RPE) cells are among the cell types that are sensitive to poisoning with methanol and its toxic metabolite formic acid. When exposed to formic acid in vitro, cultured cell lines from photoreceptors (661W) and the RPE (ARPE-19) were previously shown to accumulate similar levels of formate, but cytotoxic effects are greater in 661W cells. Here catalase and glutathione were analyzed in the two retinal cell lines to determine whether differences in these antioxidant systems contributed to cell-type-specific differences in cytotoxicity. Cells were exposed to formic acid (pH 6.8) in the culture medium in the presence or absence of a catalase activity inhibitor, 3-amino-1,2,4-triazole (AT), or a glutathione synthesis inhibitor, buthionine L-sulfoximine (BSO). Catalase protein, catalase enzyme activity, glutathione, glutathione peroxidase activity, cellular ATP, and cytotoxicity were analyzed. Compared to ARPE-19, 661W cells show lower antioxidant levels: 50% less glutathione, glutathione peroxidase and catalase protein, and 90% less catalase enzyme activity. In both cell types, formic acid treatment produced decreases in glutathione and glutathione peroxidase, and glutathione synthesis inhibition with BSO produced greater ATP depletion and cytotoxicity than formic acid treatment alone. In contrast, formate exposure produced decreases in catalase protein and activity in 661W cells, but increases in activity in ARPE-19. Treatment with the catalase inhibitor AT increased the formate sensitivity only of the ARPE-19 cells. ARPE-19 cells, therefore, may be less susceptible to formate toxicity due to higher levels of antioxidants, especially catalase, which increases on formate treatment and which has a significant cytoprotective effect for the RPE cell line.
Department of Pharmacology & Toxicology, Medical College of Wisconsin, Milwaukee, WI 53226, USA.
Jaime L
JL
Treichel
Michele M
MM
Henry
Christine M B
CM
Skumatz
Janis T
JT
Eells
Janice M
JM
Burke
D000640:Amitrole / Q000494:pharmacology; D000975:Antioxidants / Q000378:metabolism*; D019328:Buthionine Sulfoximine / Q000494:pharmacology; D002374:Catalase / Q000037:antagonists & inhibitors / Q000378:metabolism; D002478:Cells, Cultured; D019610:Cytoprotection / Q000187:drug effects*; D004338:Drug Combinations; D004791:Enzyme Inhibitors / Q000494:pharmacology; D005561:Formates / Q000633:toxicity*; D005978:Glutathione / Q000037:antagonists & inhibitors / Q000378:metabolism; D005979:Glutathione Peroxidase / Q000378:metabolism; D006801:Humans; D010786:Photoreceptor Cells / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology; D010857:Pigment Epithelium of Eye / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology
D000975:Antioxidants; D004338:Drug Combinations; D004791:Enzyme Inhibitors; D005561:Formates; C030544:formic acid; D019328:Buthionine Sulfoximine; D002374:Catalase; D005979:Glutathione Peroxidase; D005978:Glutathione; D000640:Amitrole